Ashwin Lokapally | GIWOTECH Co-Founder

A pioneering scientist in computational biology with a Ph.D. in neurobiology and postdoctoral work at the Whitehead Institute–MIT, Dr. Ashwin Lokapally leads GiwoTech Inc. in redefining drug discovery through physics-based molecular simulations and AI-powered digital twins. By accelerating vaccine and therapeutic discovery against viral targets, GiwoTech’s approach integrates biology and artificial intelligence to uncover novel treatments and enhance public health. This revolutionary platform, recognized by multiple federal agencies such as BARDA DRIVe AI Innovation Challenge, DOE, and NSF, underscores GiwoTech’s impact on healthcare innovation. Dr. Lokapally seeks non-entrepreneurial support through research alliances, public health agencies, and philanthropic partnerships, aiming for innovative solutions that improve patient outcomes globally.